Pricing Remdesivir; Instagram Co-Founder’s Covid Tracking Data

37:56
 
Share
 

Manage episode 265771185 series 2552476
By CNBC. Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio is streamed directly from their servers. Hit the Subscribe button to track updates in Player FM, or paste the feed URL into other podcast apps.

Drug maker Gilead has announced pricing for its Covid treatment Remdesivir, but it’s more expensive in the U.S. than in other developed countries. Gilead CEO Daniel O’Day explains the health care factors in setting the drug’s cost. Instagram co-founder Kevin Systrom launched the Covid-19 case tracker website RT.live in April. The site breaks down infection cases and potential for continued spread state by state. Systrom explains how RT.live is a tool for Americans to stay informed about their communities, and former FDA Commissioner Dr. Scott Gottlieb shares how the site’s data can help U.S. states stay safe. Plus, another “friend” bites the dust. Companies continue to pull their advertising spending from Facebook as the #StopHateforProfit campaign gains momentum.

Learn more about your ad choices. Visit megaphone.fm/adchoices

317 episodes